Clinical trial
Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital
NCT02068170 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital
- Lead sponsor
- KU Leuven
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- June 30, 2015
- Enrollment
- 178 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
delirium, qt-prolongation